Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs
-
- Kathy A. Gelato
- Global Drug Discovery, Bayer Pharma AG, Berlin, Germany
-
- David Adler
- Global Drug Discovery, Bayer Pharma AG, Berlin, Germany
-
- Matthias Ocker
- Global Drug Discovery, Bayer Pharma AG, Berlin, Germany
-
- Bernard Haendler
- Global Drug Discovery, Bayer Pharma AG, Berlin, Germany
書誌事項
- 公開日
- 2016-01-22
- DOI
-
- 10.1517/14728222.2016.1134490
- 公開者
- Informa UK Limited
この論文をさがす
収録刊行物
-
- Expert Opinion on Therapeutic Targets
-
Expert Opinion on Therapeutic Targets 20 (7), 783-799, 2016-01-22
Informa UK Limited